Skip to main content

Find Clinical Trials

Home
Conditions
Recurrent Melanoma

Clinical trial condition

Recurrent Melanoma

Explore clinical trials studying Recurrent Melanoma. Study availability and eligibility vary by location and protocol.

83 public trials 2 recruiting studies

Refine in advanced search Browse all conditions

Recurrent Melanoma trial results

Completed

Sorafenib With Either Temsirolimus or Tipifarnib in Treating Patients With Stage IV Malignant Melanoma That Cannot Be Removed By Surgery

NCT00281957

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +11 more
Locations: University of Arkansas for Medical Sciences Little Rock, Arkansas, United States

East Bay Radiation Oncology Center Castro Valley, California, United States

Eden Hospital Medical Center Castro Valley, California, United States

Valley Medical Oncology Consultants-Castro Valley Castro Valley, California, United States

View all 173 locations

View Trial Details

Completed

Dasatinib in Treating Patients With Stage III Melanoma That Cannot Be Removed By Surgery or Stage IV Melanoma

NCT00436605

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +14 more
Locations: Yale University New Haven, Connecticut, United States

Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States

View Trial Details

Completed

Viral Therapy in Treating Patients With Metastatic Melanoma

NCT00651157

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +11 more
Locations: Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

Vaccine Therapy Following Therapeutic Autologous Lymphocytes and Cyclophosphamide in Treating Patients With Metastatic Melanoma

NCT01339663

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +11 more
Locations: Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

Sorafenib and Temsirolimus in Treating Patients With Metastatic, Recurrent, or Unresectable Melanoma

NCT00349206

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +12 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Carboplatin, Paclitaxel, and Bevacizumab in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery

NCT00255762

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +11 more
Locations: North Central Cancer Treatment Group Rochester, Minnesota, United States

View Trial Details

Completed

Melphalan With or Without Tumor Necrosis Factor in Treating Patients With Locally Advanced Melanoma of the Arm or Leg

NCT00003789

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +11 more
Locations: American College of Surgeons Oncology Group Durham, North Carolina, United States

View Trial Details

Completed

Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or Lymphomas

NCT00101270

Conditions: Astrocytoma, Burkitt Lymphoma, Childhood Burkitt Lymphoma, +115 more
Locations: COG Phase I Consortium Arcadia, California, United States

View Trial Details

Completed

Tipifarnib in Treating Patients With Metastatic Malignant Melanoma

NCT00060125

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +11 more
Locations: Cancer and Leukemia Group B Chicago, Illinois, United States

View Trial Details

Completed

Interleukin-12 and Interferon Alfa in Treating Patients With Metastatic Malignant Melanoma

NCT00026143

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +11 more
Locations: Cancer and Leukemia Group B Chicago, Illinois, United States

View Trial Details